Abstract
The reactive aldehyde, 4-hydroxynonenal (HNE), is recognized as a product of lipid peroxidation, which binds to macromolecules, in particular proteins. HNE-modified proteins (HNE-MP) have been shown to accumulate during ageing, generally by using polyclonal antibodies, which increase the possibility of detecting false positives. Therefore, we have used a genuine monoclonal antibody specific for HNE-His adducts of proteins/peptides, which were revealed by immunoblotting method for whole-cell HNE-MP measurements in serially passaged human facial skin fibroblasts undergoing ageing in vitro. There was a significant increase in the levels of HNE-MP in serially passaged cells approaching a near senescent state at high passage level (P-61), as compared with low passage level (P-11) young and middle-aged (P-27) cells. However, if the cells were analyzed soon after re-initiation from the frozen samples with little further passaging, the amount of HNE-MP was low even in relatively high passage level (P-37) cells, which is an indication of selective elimination of cells with high molecular damage during the process of thawing and re-initiation in culture. This pilot study on normal human facial skin fibroblasts shows that HNE-MP detection by monoclonal antibody-based dot blot method can be used as a marker for age-related accumulation of lipid peroxidative molecular damage, and could be useful for testing and monitoring the effects of potential skin care products on ageing parameters.
References
Ahmed EK, Picot CR, Bulteau A-L, Friguet B (2007) Protein oxidative modifications and replicative senescence of WI-38 human embryonic fibroblasts. Ann N Y Acad Sci 1119:88–96
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein–dye binding. Anal Biochem 72:248–254
Dalleau S, Baradat M, Guéraud F, Huc L (2013) Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ 20:1615–1630
Guichardant MEA, Bernoud-Hubac N, Chantegrel B, Deshayes C, Lagarde M (2002) Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids. Prostaglandins Leukot Essent Fatty Acids 67:147–149
Levine RL, Stadtman ER (2001) Oxidative modification of proteins during aging. Exp Gerontol 36:1495–1502
Nedić O, Rattan SIS, Grune T, Trougakos IP (2013) Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology. Free Radic Res 47:28–38
Negre-Salvayre A, Auge N, Ayala V, Basaga H, Boada J, Brenke R, Chapple S, Cohen G, Feher J, Grune T et al (2010) Pathological aspects of lipid peroxidation. Free Radic Res 44:1125–1171
Petropoulos I, Conconi M, Wang X, Hoenel B, Brégégère F, Milner Y, Friguet B (2000) Increase of oxidatively modified protein is associated with a decrease of proteasome activity and content in aging epidermal cells. J Gerontol A Biol Sci Med Sci 55:B220–B227
Rattan SIS (2006) Theories of biological aging: genes, proteins, and free radicals. Free Radic Res 40:1230–1238
Rattan SIS (2008a) Increased molecular damage and heterogeneity as the basis of aging. Biol Chem 389:267–272
Rattan SIS (2008b) Hormesis in aging. Ageing Res Rev 7:63–78
Rattan SIS (2012a) Cell senescence in vitro. In: eLS. Wiley, Chichester
Rattan SIS (2012b) Rationale and methods of discovering hormetins as drugs for healthy ageing. Expert Opin Drug Discov 7:439–448
Rattan SIS, Kryzch V, Schnebert S, Perrier E, Nizard C (2013) Hormesis-based anti-aging products: a case study of a novel cosmetic. Dose-Response 11:99–108
Riahi Y, Cohen G, Shamni O, Sasson S (2010) Signaling and cytotoxic functions of 4-hydroxyalkenals. Am J Physiol Endocrinol Metab 299:E879–E886
Siems W, Grune T (2003) Intracellular metabolism of 4-hydroxynonenal. Mol Aspects Med 24:167–175
Spoljaric D, Cipak A, Horvatic J, Andrisic L, Waeg G, Zarkovic N, Jaganjac M (2011) Endogenous 4-hydroxy-2-nonenal in microalga Chlorella kessleri acts as a bioactive indicator of pollution with common herbicides and growth regulating factor of hormesis. Aquat Toxicol 105:552–558
Waeg G, Dimsity G, Esterbauer H (1996) Monoclonal antibodies for detection of 4-hydroxynonenal modified proteins. Free Radic Res 25:149–159
Weber D, Milkovic L, Bennett SJ, Griffiths HR, Zarkovic N, Grune T (2013) Measurement of HNE–protein adducts in human plasma and serum by ELISA—comparison of two primary antibodies. Redox Biol 1:226–233
Wildburger R, Mrakovcic L, Stroser M, Andrisic L, Sunjic SB, Zarkovic K, Zarkovic N (2009) Lipid peroxidation and age-associated diseases—cause or consequence?: Review. Turkiye Klinikleri J Med Sci 29:189–193
Zarkovic N (2003) 4-Hydroxynonenal as a bioactive marker of pathophysiological processes. Mol Aspects Med 24:281–291
Zarkovic N, Cipak A, Jaganjac M, Borovic S, Zarkovic K (2013) Pathophysiological relevance of aldehydic protein modifications. J Proteomics. doi:10.1016/j.jprot.2013.02.00
Acknowledgments
This work was supported by the EU COST Action CM1001, and by the Croatian Ministry of Science, Education, and Sports. Laboratory of Cellular Ageing is financially partially supported by a research grant from LVMH Recherche, Saint Jean de Braye, France.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jørgensen, P., Milkovic, L., Zarkovic, N. et al. Lipid peroxidation-derived 4-hydroxynonenal-modified proteins accumulate in human facial skin fibroblasts during ageing in vitro. Biogerontology 15, 105–110 (2014). https://doi.org/10.1007/s10522-013-9482-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10522-013-9482-z